Table 3.

Post-ABSCT treatment, toxicities and supportive care

Parameters	Overall cohort	Outpatient treatment	Hospital admission	P-value
ABSCT number, n	21	14	7	/
Treatment duration
Overall, days	21 (18–31)	21 (18–25)	22 (19–31)	0.38
Days as outpatient	19 (8–25)	21 (18–25)	15 (8–19)	<0.01
Days as inpatient	0 (0–18)	/	5 (2–18)	<0.01
Reason for hospital admission, n (%)				/
Neutropenic fever ≥72 h	4 (19)	/	4 (57)
Grade III stomatitis	2 (10)	/	2 (29)
Other	1 (5)	/	1 (14)
Toxicities
Stomatitis, n (%)
I	17 (81)	13 (93)	4 (57)
II	2 (10)	1 (7)	1 (14)
III	2 (10)	0 (0)	2 (29)
Neutropenic fever
n, (%)	14 (67)	8 (57)	6 (86)	0.34
No. of days with fever	3 (1–10)	2 (1–7)	4 (2–10)	0.14
Diarrhoea, n (%)	1 (5)	1 (7)	0 (0)	1.00
Pulmonary infection, n (%)	0 (0)	0 (0)	0 (0)	1.00
Urinary tract infection, n (%)	1 (5)	0 (0)	1 (14)	0.33
Positive blood cultures, n (%)
Peripheral	4 (19)	1 (7)	3 (43)	0.09
Central	0 (0)	0 (0)	0 (0)	1.00
Port catheter infection, n (%)
Suspicion of	3 (14)	0 (0)	3 (43)	0.03
Proven	0 (0)	0 (0)	0 (0)	1.00
Port catheter explantation	3 (14)	0 (0)	3 (43)	0.03
SAE, n (%)	0 (0)	0 (0)	0 (0)	1.00
Support/Intervention
Red cell transfusion, n (%)	6 (29)	3 (21)	3 (43)	0.35
Platelet transfusion, n (%)	15 (71)	9 (64)	6 (86)	0.61
i.v. antibiotics
In case of neutropenic fever, n (%)	14 (67)	8 (57)	6 (86)	0.34
At subfebrile temperature, n (%)	5 (24)	4 (29)	1 (14)	0.62
Overall, days	7 (4–14)	7 (4–10)	8 (4–14)	0.61
Days as outpatient	6 (1–10)	7 (4–10)	1 (0–6)	/
Days as inpatient	5 (2–14)	/	5 (2–14)	/

ABSCT autologous blood stem cell transplantation, i.v. intravenous, no. number, SAE severe adverse event. Unless otherwise indicated, data are given as medians (range)